These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy. Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769 [TBL] [Abstract][Full Text] [Related]
8. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a. Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM Adv Exp Med Biol; 1984; 174():455-61. PubMed ID: 6741739 [No Abstract] [Full Text] [Related]
10. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Pestronk A; Cornblath DR; Ilyas AA; Baba H; Quarles RH; Griffin JW; Alderson K; Adams RN Ann Neurol; 1988 Jul; 24(1):73-8. PubMed ID: 2843079 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM J Immunol; 1984 Apr; 132(4):1793-7. PubMed ID: 6699401 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection. Gisslén M; Lekman A; Fredman P Infection; 2000; 28(3):143-8. PubMed ID: 10879637 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699 [TBL] [Abstract][Full Text] [Related]
15. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies. Koga M; Gilbert M; Li J; Yuki N PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522 [TBL] [Abstract][Full Text] [Related]
16. [Antibodies to GM1 and GQ1b gangliosides]. Obayashi H; Saida T; Fukui M; Hasegawa G; Nakamura N; Yoshikawa T Nihon Rinsho; 2005 Jul; 63 Suppl 7():653-5. PubMed ID: 16111360 [No Abstract] [Full Text] [Related]
17. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera. Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101 [TBL] [Abstract][Full Text] [Related]
19. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands. Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944 [TBL] [Abstract][Full Text] [Related]
20. Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias? Kowal L; Gajus MA; Kornberg AJ Clin Exp Ophthalmol; 2004 Aug; 32(4):411-4. PubMed ID: 15281977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]